-+ 0.00%
-+ 0.00%
-+ 0.00%

*Celldex Therapeutics: Sam Martin, Chief Fincl Officer, Informed the Co of His Plans to Retire in 2027 >CLDX

Dow Jones·07/15/2026 20:03:00

Please log in to view news